Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial

被引:54
作者
Rafiq, Rachida [1 ]
Prins, Hendrik J. [2 ]
Boersma, Wim G. [2 ]
Daniels, Johannes M. A. [3 ]
den Heijer, Martin [1 ]
Lips, Paul [1 ]
de Jongh, Renate T. [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Internal Med & Endocrinol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands
[2] Northwest Hosp Grp, Dept Pulm Dis, Alkmaar, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2017年 / 12卷
关键词
chronic obstructive pulmonary disease; vitamin D; physical performance; muscle strength; pulmonary function; OBSTRUCTIVE PULMONARY-DISEASE; QUADRICEPS STRENGTH; METAANALYSIS; MORTALITY; HEALTH; STANDARDIZATION; EXACERBATIONS; ASSOCIATION; ADULTS; MASS;
D O I
10.2147/COPD.S132117
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Although vitamin D is well known for its function in calcium homeostasis and bone mineralization, several studies have shown positive effects on muscle strength and physical function. In addition, vitamin D has been associated with pulmonary function and the incidence of airway infections. As vitamin D deficiency is highly prevalent in chronic obstructive pulmonary disease (COPD) patients, supplementation might have a beneficial effect in these patients. Objective: To assess the effect of vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients. Secondary outcomes are pulmonary function, handgrip strength, exacerbation rate, and quality of life. Methods: We performed a randomized, double-blind, placebo-controlled pilot trial. Participants were randomly allocated to receive 1,200 IU vitamin D3 per day (n=24) or placebo (n=26) during 6 months. Study visits were conducted at baseline, and at 3 and 6 months after randomization. During the visits, blood was collected, respiratory muscle strength was measured (maximum inspiratory and expiratory pressure), physical performance and 6-minute walking tests were performed, and handgrip strength and pulmonary function were assessed. In addition, participants kept a diary card in which they registered respiratory symptoms. Results: At baseline, the mean (standard deviation [SD]) serum 25-hydroxyvitamin D (25(OH) D) concentration (nmol/L) was 42.3 (15.2) in the vitamin D group and 40.6 (17.0) in the placebo group. Participants with vitamin D supplementation had a larger increase in serum 25(OH) D compared to the placebo group after 6 months (mean difference (SD): + 52.8 (29.8) vs + 12.3 (25.1), P< 0.001). Primary outcomes, respiratory muscle strength and physical performance, did not differ between the groups after 6 months. In addition, no differences were found in the 6-minute walking test results, handgrip strength, pulmonary function, exacerbation rate, or quality of life. Conclusion: Vitamin D supplementation did not affect (respiratory) muscle strength or physical performance in this pilot trial in vitamin D-deficient COPD patients.
引用
收藏
页码:2583 / 2592
页数:10
相关论文
共 32 条
[1]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[2]   The Effects of Vitamin D on Skeletal Muscle Strength, Muscle Mass, and Muscle Power: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Beaudart, Charlotte ;
Buckinx, Fanny ;
Rabenda, Veronique ;
Gillain, Sophie ;
Cavalier, Etienne ;
Slomian, Justine ;
Petermans, Jean ;
Reginster, Jean-Yves ;
Bruyere, Olivier .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (11) :4336-4345
[3]   Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials [J].
Bischoff-Ferrari, H. A. ;
Dawson-Hughes, B. ;
Staehelin, H. B. ;
Orav, J. E. ;
Stuck, A. E. ;
Theiler, R. ;
Wong, J. B. ;
Egli, A. ;
Kiel, D. P. ;
Henschkowski, J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :843
[4]   Supplemental vitamin D and physical performance in COPD: a pilot randomized trial [J].
Bjerk, Sonja M. ;
Edgington, Bradley D. ;
Rector, Thomas S. ;
Kunisaki, Ken M. .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 :97-104
[5]   Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey [J].
Black, PN ;
Scragg, R .
CHEST, 2005, 128 (06) :3792-3798
[6]   Handgrip weakness and mortality risk in COPD: a multicentre analysis [J].
Burtin, Chris ;
ter Riet, Gerben ;
Puhan, Milo A. ;
Waschki, Benjamin ;
Garcia-Aymerich, Judith ;
Pinto-Plata, Victor ;
Celli, Bartolome ;
Watz, Henrik ;
Spruit, Martijn A. .
THORAX, 2016, 71 (01) :86-87
[7]   The 6-min walk distance, peak oxygen uptake, and mortality in COPD [J].
Cote, Claudia G. ;
Pinto-Plata, Victor ;
Kasprzyk, Kyra ;
Dordelly, Luis J. ;
Celli, Bartolome R. .
CHEST, 2007, 132 (06) :1778-1785
[8]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[9]   Various calibration procedures result in optimal standardization of routinely used 25(OH)D ID-LC-MS/MS methods [J].
Dirks, Niek F. ;
Vesper, Hubert W. ;
van Herwaarden, Antonius E. ;
van den Ouweland, Jody M. W. ;
Kema, Ido P. ;
Krabbe, Johannes G. ;
Heijboer, Annemieke C. .
CLINICA CHIMICA ACTA, 2016, 462 :49-54
[10]  
Evans JA, 2009, RESP CARE, V54, P1348